The PE Ratio as of November 2025 (TTM) for Zynerba Pharmaceuticals, Inc. (ZYNE) is -1.65

According to Zynerba Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -1.65. This represents a change of 153.01% compared to the average of -0.65 of the last 4 quarters.

Zynerba Pharmaceuticals, Inc. (ZYNE) Historical PE Ratio (quarterly & annually)

How has ZYNE PE Ratio performed in the past?

The mean historical PE Ratio of Zynerba Pharmaceuticals, Inc. over the last ten years is -18.82. The current -1.65 PE Ratio has changed 774.27% with respect to the historical average. Over the past ten years (40 quarters), ZYNE's PE Ratio was at its highest in in the June 2023 quarter at -0.38. The PE Ratio was at its lowest in in the March 2014 quarter at -96.91.

Zynerba Pharmaceuticals, Inc. (ZYNE) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Zynerba Pharmaceuticals, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Zynerba Pharmaceuticals, Inc. (ZYNE) Average PE Ratio

How has ZYNE PE Ratio performed in the past?

The current PE Ratio of Zynerba Pharmaceuticals, Inc. (ZYNE) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Zynerba Pharmaceuticals, Inc. (ZYNE) PE Ratio vs. Peers

How is ZYNE’s PE Ratio compared to its peers?

Zynerba Pharmaceuticals, Inc.’s PE Ratio is less than The Valens Company Inc. (-0.88), less than Chicago Atlantic BDC, Inc. (10.04), greater than Quince Therapeutics, Inc. (-3.67), greater than DURECT Corporation (-17.05), less than Akoya Biosciences, Inc. (-1.35), less than Zomedica Corp. (-1.12), less than Bonk, Inc. (-0.75), less than IGM Biosciences, Inc. (-1.46), greater than MindWalk Holdings Corp. (-4.37), less than Surface Oncology, Inc. (-0.91),

Build a custom stock screener for Zynerba Pharmaceuticals, Inc. (ZYNE) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Zynerba Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Zynerba Pharmaceuticals, Inc. (ZYNE) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Zynerba Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.